The first dedicated fund for autism innovation.
Our mission is to invest in life science breakthroughs & therapeutics, digital health, innovative service companies, and life beyond childhood.
Concentrating capital, expertise, and community to accelerate advances in autism.
Autism affects 1 in 54 American children.
Half have serious comorbidities.
Investments in research, products and services
remain fragmented and often redundant.
Solid. Experienced. Motivated.
Led by a team of cross-functional domain experts.
Managing Director & CIO
Dr. Hubbert is Managing Director of the Autism Impact Fund where she leads the Life Sciences practice. Charlotte has over fifteen years basic science research experience and over ten years biotech investment background most recently as Partner and head of Gates Foundation Venture Capital.
Mr. Male is Managing Director and Co-Founder of the Autism Impact Fund where he oversees the firm and leads the Business Services practice. Chris has over ten years experience leading venture and middle-market equity financing across business services, impact, and real estate, most recently as Managing Director of RBG Capital, LLC, his family's private investment arm.
Venture Capitalist NEA, Forbes Midas List
Sigrid joined the Autism Impact Fund as an Executive Advisor in 2020 after a successful 25+ year career in Venture Capital. Most recently she was a Venture Partner at Aberdare Ventures where she served on the Board of Directors of several Aberdare portfolio companies.
Mr. O'Callaghan is a Co-Founder of the Autism Impact Fund, bringing with him 30+ years of experience in the private equity industry as recruiting partner, investor, human behaviorist, business partner, confidant/advisor. Brian founded CPI in 1996, the first recruiting firm to focus within the investment industry.
Bold strategy + Biology + Technology = Audacious goal achieved.